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ABSTRACT 
 
Phosphate (Pi) homeostasis is regulated by renal, intestinal, and endocrine 
mechanisms where Pi intake stimulates PTH, FGF23, and phosphaturia. The 
mechanisms underlying the early adaptive phase and the role of the intestine remained 
ill defined. We investigated the mineral, endocrine, and renal response to intravenous 
and intragastric Pi loading in rats during the first 4 hours after administration. 
Intravenous Pi at the highest dose (0.5 mmol) caused a transient rise in plasma Pi, 
phosphaturia within 10 minutes accompanied by a transient increase in creatinine 
clearance. Plasma calcium fell and PTH increased within 10 minutes remaining low or 
high, respectively. FGF23, 1,25-(OH)2-vitamin D3, and insulin did not respond but 
dopamine increased by 4 hours. Gastric Pi-loading had no effect on plasma Pi and 
calcium levels but elicited a similar phosphaturia and endocrine responses as 
intravenous application with a delay of 20-30 minutes. Intravenous or gastric loading 
was paralleled by decreased expression and activity of renal Pi transporters after 4 
hours. NaCl loading had no effect on all parameters. The role of PTH was examined in 
parathyroidectomized (PTX) rats where only intravenous Pi loading caused a blunted 
and transient phosphaturia paralleled by higher creatinine clearance and a more 
pronounced fall in plasma calcium. Pi-loading did not reduce expression and activity of 
Pi transporters in PTX rats. Thus, an intravenous or intestinal Pi bolus causes rapid 
phosphaturia depending on elevated PTH and downregulation of renal Pi transporters. 
There is no evidence supporting a role of the intestine in stimulating renal clearance of 
Pi. 
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INTRODUCTION 
 
 Phosphate (Pi) homeostasis is achieved by the balanced actions of intestinal 
absorption, renal reabsorption, and bone mineralization/demineralization. Intestinal 
absorption and renal reabsorption of Pi are mostly mediated by Na+-dependent Pi 
(Na/Pi) cotransporters from the SLC34 family of solute carriers, consisting of the renal 
NaPi-IIa and NaPi-IIc, and the intestinal NaPi-IIb transporters1. The activity and 
expression of these transporters is downregulated in response to increased dietary Pi 
intake whereas Pi deficiency promotes their upregulation1-2. The adaptive regulation of 
renal and intestinal Pi transport is at least in part mediated by several hormones 
including fibroblast growth factor-23 (FGF23), 1,25-dihydroxy-vitamin D3 (1,25-(OH)2- 
vitamin D3), parathyroid hormone (PTH), insulin and dopamine
3-7. PTH and FGF23 rise 
in response to Pi intake and alone or together downregulate renal Pi transporters 
increasing phosphaturia6, 8. Similarly, dopamine stimulates renal Pi excretion by 
reducing renal Pi transporter activity and expression 9-11. 1,25-(OH)2-vitamin D3 levels 
increase during Pi deficiency and enhance renal and intestinal Pi absorption 8, 12-14. Also 
insulin stimulates expression of renal Pi transporters and reduces phosphaturia15. The 
actions of FGF23, PTH, and 1,25-(OH)2-vitamin D3 are coupled through multiple 
negative and positive feedback loops 6, 8, 16.  
 However, the exact roles of these hormones in the acute and chronic response to 
changes in Pi intake are not fully defined. Moreover, the existence and role of additional 
factors and mediators in the control of Pi homeostasis have been proposed17-18. Klotho, 
a cofactor for FGF23 signaling, also exerts direct effects on renal Pi and calcium 
transporters independent from FGF236, 19-20. MEPE and sFRP4 may act on renal and 
extrarenal targets to lower plasma Pi21-23.  Also the existence of a putative intestinal 
phosphaturic factor has been postulated based on the rapid phosphaturic effect of 
duodenal Pi infusion, the absence of changes in plasma Pi, PTH and FGF23, its 
independence from renal innervation, and the phosphaturic effect of duodenal extracts 
from Pi infused rats 24. However in humans, acute enteral and parenteral Pi loads cause 
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dose dependent changes in phosphaturia only upon changes in plasma Pi and PTH and 
a similar phosphaturic response is observed with both routes of Pi administration. Thus, 
in contrast to rodents, the human data is not consistent with the presence of an 
intestinal Pi sensor 25. Local Pi sensing mechanisms in kidney and other organs may be 
involved in sensing changes in dietary Pi intake and may mediate or modulate some of 
the effects on renal Pi handling. Evidence for Pi sensing has been obtained from 
isolated parathyroid gland cells in vitro 26-27, the opossum kidney derived OK cell line 28-
29, bone and vascular cells 30-32 
 
 The aim of this study was to investigate the endocrine, mineral, and renal 
responses to acute Pi loading in rats and to test for evidence for a role of the intestine in 
determining the adaptive response by administering Pi either intravenously or 
intragastrically. 
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RESULTS 
 
Phosphate loading rapidly elicits phosphaturia 
 
 Intravenous infusion of a Pi bolus (500 moles Pi) caused a rapid and transient 
increase in plasma Pi concentration in intact rats (Figure 1A) with a peak after 10 
minutes.  Two hours after infusion, plasma Pi had returned to baseline values. A 
significant, although blunted increase in plasma Pi was observed 10 minutes upon 
infusion of 150 moles but not with 50 moles Pi (supplementary Figure 1A). In 
contrast, plasma Pi did not change in rats gavaged with 500 moles Pi (Figure 1A). The 
concentration of plasma Pi remained normal after intravenous or intragastric 
administration of 500 or 150 moles NaCl (Figure 1A and supplementary Figure 2A). 
 
 Intravenous infusion of 500 moles Pi rapidly and strongly increased urinary Pi 
excretion within 10 minutes. Although phosphaturia tended to decrease after 30 
minutes, it remained high over 4 hours after administration (Figure 1B). Infusions of 150 
moles and 50 moles Pi failed to induce any significant phosphaturic response 
(supplementary Figure 1B). Intragastric administration of 500 moles Pi increased 
urinary excretion of Pi to a similar extent as intravenous administration, however, the 
onset of phosphaturia was delayed compared to infusion, reaching significance only 60 
minutes after the Pi bolus (Figure 1B). Phosphaturia remained high over 4 hours post 
gavage (Figure 1B). Changes in the fractional excretion of Pi after the Pi bolus 
paralleled urinary Pi concentration (supplementary Figure 3A). Neither intravenous 
infusion nor gavage of 500 or 150 moles NaCl affected the urinary excretion of Pi 
(Figure 1B and supplementary Figure 2B).  
 
 Creatinine clearance significantly increased within 10 minutes after intravenous 
application of 500 moles Pi and thereafter rapidly normalized (Figure 1C). Intragastric 
loading with 500 moles Pi did not alter creatinine clearance (Figure 1C). Similarly, 
administration of 500 or 150 moles NaCl by infusion or gavage had no effect (Figure 
1C and data not shown).  
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 The accumulative urinary excretion of Pi showed a similar level after 4 hours of 
the oral or intravenous bolus (Figure 1D). Although a delay was observed in  the gavage 
group, both groups had excreted comparable amounts of Pi four 4 post application, with 
mean values of around 230 and 280 µmoles Pi, respectively,  representing about 50-
60% of the initial Pi load (500 moles). 
 
 In order to examine possible organ storage of the non-excreted Pi, we assessed 
the Pi content in femurs, liver and skeletal muscle in tissues from rats infused and 
gavaged with Pi or NaCl. As expected, the concentration of Pi in femurs was higher (10 
to 20 times) than in the other two organs (Supplementary Figure 4). However, in all 
three tissues, similar levels of Pi were measured in samples from control and Pi-loaded 
rats. 
 
 The concentration of total Ca2+ in plasma slightly but significantly decreased 
upon intravenous infusion of 500 moles Pi (Figure 2A). The reduction was already 
detectable 10 minutes after the Pi bolus and although it tended to normalize at the latest 
time points, plasma Ca2+ remained low until the end of the experiment (4 hours). Similar 
changes were observed upon Pi infusion with 150 moles Pi, but not with 50 moles Pi 
(supplementary Figure 1C). In contrast, total plasma Ca2+ did not change significantly 
after intragastric administration of 500 moles Pi (Figure 2A). Infusion or gavage with 
either 500 or 150 moles NaCl did not alter total plasma Ca2+ (Figure 2A and 
supplementary Figure 2C).  
 
 The urinary excretion of Ca2+ remained unchanged after intravenous or 
intragastric Pi or NaCl application (Figure 2B, supplementary Figures 1D and 2D). 
However, infusion with Pi  or NaCl caused a small, non-significant, and transient 
increase in urinary Ca2+ excretion possibly reflecting an acute volume load (Figure 2B).  
 
Phosphate loading causes an immediate PTH rise 
 
 In intact animals, intravenous infusion of 500 moles Pi increased plasma intact 
PTH levels six-fold within 10 minutes, whereas in gavaged rats a two-fold increase was 
detected after 25 minutes paralleling or even preceding the increase in urinary Pi 
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excretion (Figure 3A). In both cases, PTH remained high 4 hours after Pi-administration 
(Figure 3A). No changes in the plasma levels of intact FGF23 (Figure 3B), 1,25-(OH)2 
vitamin D3 (Figure 3C) and insulin (Figure 3D) were observed in rats after Pi 
administration. Plasma dopamine significantly increased at 4 hours after 500 moles Pi 
infusion but not gavage (Figure 3E) whereas urine dopamine was not altered (Figure 
3F). Infusion and gavage with saline had no effect on the hormones analyzed.  
 
The phosphate load reduces renal phosphate transporter activity and expression 
  
 Flux measurements of 32Pi and 3H-D-glucose were performed in BBMV isolated 
from kidneys collected 40 minutes and 4 hours after 500 moles Pi or saline application 
to assess proximal tubular luminal phosphate transporter activity.  In BBMV from 
kidneys extracted 40 minutes after application, all 32Pi uptake components were similar 
in Pi loaded and control samples (Figure 4A and B). Similarly, no differences were 
detected for the Na+-dependent uptake of D-glucose (Figure 4E).  In contrast, the total 
Na+-dependent as well as SLC34-mediated 32Pi-transport activities were reduced in 
kidneys 4 hours after infusion with 500 moles Pi  (Figure 4C). 32Pi fluxes also 
decreased, though non-significantly, in the Pi-gavaged animals after 4 hours (Figure 
4D). The Na+-dependent uptake of D-glucose remained unaffected 4 hours in Pi infused 
or gavaged animals (Figure 4F).  
 The abundance of the major renal Pi transporters NaPi-IIa and NaPI-IIc in renal 
BBMV isolated 40 minutes after infusion or gavage with Pi or saline was unchanged 
(Figure 5A and 5B). The abundance of both cotransporters was significantly reduced in 
kidneys collected 4 hours after infusion with 500 moles Pi (Figure 5C), whereas the 
expression of NaPi-IIa but not NaPi-IIc was diminished 4 hours after intragastric loading 
(Figure 5D).  
 
Parathyroid hormone is required to clear the acute phosphate load 
 
 Since PTH increased very rapidly upon Pi loading and paralleled or even 
preceded phosphaturia, we tested the role of PTH in the adaptive response in 
parathyroidectomized (PTX) rats.  Infusion of 500 moles Pi, caused a rapid increase in 
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plasma Pi in PTX rats (Figure 6A) peaking after 10 minutes and decreasing thereafter. 
However, whereas the levels of Pi fully normalized within 2 hours post-infusion in intact 
rats, Pi levels remained elevated until the end of the experiment in PTX animals (Figure 
6A). Gavage of 500 moles Pi in PTX rats induced a slow rise in plasma Pi (Figure 6A) 
in contrast with the lack of effect of the Pi gavage in intact animals (Figure 1A). 
Administration of saline to PTX rats by infusion or gavage did not alter plasma Pi 
(Figure 6A). 
 
 Infusion with 500 moles Pi induced a fast but small increase in urinary excretion 
of Pi in PTX rats (Figure 6B). Maximal phosphaturia was detected 10 min post-infusion 
similar to intact animals (Figure 1B). However, phosphaturia returned to baseline within 
2 hours after infusion in PTX rats despite elevated plasma Pi levels (Figure 6B). 
Moreover, gavage of Pi in PTX rats failed to elicit any significant phosphaturia (Figure 
6B). Neither infusion nor gavage with saline affected urinary Pi (Figure 6B). 
 
 In PTX rats, creatinine clearance increased within 10 minutes of 500 moles Pi 
infusion and rapidly normalized thereafter, whereas it was not altered with either Pi 
gavage or saline administration (Figure 6C).  
 
 The accumulative urinary excretion of Pi over 4 hours in PTX rats infused with 
500 moles Pi was of about 30 µmol (Figure 6D) equivalent to about 6% of the Pi load. 
The accumulative urinary excretion of Pi over 4 hours in PTX rats receiving Pi by 
gavage was about 3 µmol (Figure 6D), representing less than 1% of the Pi load.  
 
 The content of Pi was higher in femurs than liver and muscle in PTX animals, 
and no differences were found between organs extracted from saline treated and Pi-
loaded rats (Supplementary Figure 5).  
 
 Plasma total Ca2+ decreased slightly within 10 minutes upon 500 moles Pi 
infusion in PTX rats (Figure 7A) and remained low until the end of the experiment. In 
contrast, plasma total Ca2+ did not change significantly in Pi gavaged PTX rats (Figure 
7A). Administration of 150 moles NaCl by infusion or gavage did not alter plasma Ca2+.  
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Urinary excretion of Ca2+ in PTX showed no significant changes after administration of 
Pi or saline (Figure 7B).  
 
 As expected, plasma PTH was undetectable in PTX rats under all conditions 
(Figure 8A). In contrast to intact rats, FGF23 was elevated in PTX animals 4 hours after 
oral or intravenous Pi loading (Figure 8B). The plasma concentrations of 1,25-(OH)2-
vitamin D3 (Figure 8C), insulin (Figure 8D) and dopamine (Figure 8E) as well as of urine 
dopamine (Figure 8F) remained unchanged under all conditions. 
 
Parathyroid hormone downregulates renal phosphate transporters in response to 
acute phosphate loading 
 
 Flux measurements of 32Pi and 3H-D-glucose in BBMV from PTX rat kidneys 
collected 4 hours post-loading were similar in samples from Pi-loaded and controls 
(Figure 9). The protein abundance of NaPi-IIa and NaPi-IIc in PTX rats were similar in 
the Pi loaded and saline treated animals, 4 hours post-administration (Figure10).  
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DISCUSSION 
 
 Acute and chronic changes in plasma Pi elicit adaptive responses in 
several hormones that regulate renal and intestinal epithelia (re)absorbing Pi 1-2, 8. High 
dietary Pi increases the phosphaturic hormones PTH, FGF-23, and dopamine while 
decreasing the levels of 1,25-(OH)2-vitamin D3 
7-9, 33 resulting in reduced expression and 
activity of Na/Pi cotransporters in renal and intestinal epithelia, blunting intestinal Pi 
absorption and  increasing urinary excretion. However, there are conflicting data 
regarding the sequence of events triggered by high dietary Pi, as well as regarding the 
nature of the trigger itself. PTH may have a key role in the acute renal response, with 
other hormones coming into play only later on 25, 34-36, but the presence of yet-
unidentified intestinal factor(s) stimulating renal Pi excretion independent from PTH has 
been proposed 37. Here, we administered a Pi load to rats, both intravenously (to 
bypass the gastrointestinal tract) and intragastrically, and compared the acute 
responses in intact and PTX animals.  
 
 Our data demonstrate that in comparison to equimolar NaCl infusions and the 
time point zero the acute infusion of Pi elicited a dose-dependent response that 
consisted at the highest dose of 1) an immediate but transient rise in plasma Pi, 2) an 
early and transient increase in creatinine clearance, 3) a rapid phosphaturic response, 
4) a fall in plasma total calcium, 5) a rapid and sustained phosphaturia, and 6) a 
reduced expression and activity of renal Pi transporters. Intragastric application of Pi 
caused a qualitatively similar response in the cumulative Pi excretion without a 
significant change in creatinine clearance, no obvious hyperphosphatemia, a lower and 
delayed rise in PTH, a non-significant reduction in renal Pi transporter activity and lower 
expression of only NaPi-IIa but not NaPi-IIc, and a slower onset in phosphaturia. 
Infusion or gavage of NaCl had no effects.  
 
 Several points are of major interest: the onset of phosphaturia is paralleled by a 
rise in PTH in infused and gavaged animals and precedes changes in plasma dopamine 
whereas levels of 1,25-(OH)2-vitamin D3, FGF23, insulin, and urine dopamine were not 
altered suggesting an important role of PTH. Early phosphaturia (40 minutes) occurred 
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in infused animals without obvious changes in the activity or abundance of renal Pi 
transporters expressed in the brush border membrane of the proximal tubule which may 
be explained at least in part by a higher tubular load in the infused animals as creatinine 
clearance had more than doubled and plasma Pi levels were elevated. However, we 
noted also a partial dissociation between the degree of phosphaturia, Pi-transport 
activities in brush border membrane vesicles, and the abundance of the NaPi-IIa and 
NaPi-IIc transporters as most evident in the Pi gavaged group after 4 hours. Activity of 
NaPi-IIa transporters in the brush border membrane is influenced by lipid composition of 
the plasma membrane, in-situ cleavage by klotho, and possibly by regulated association 
with and dissociation from NHERF1 through phosphorylation of NHERF1 stimulated by 
PTH or dopamine 19, 38-40. We did not obtain evidence for cleavage of NaPi-IIa as 
evident from immunoblotting but changes in lipid composition or NHERF1 
phosphorylation were not tested and may contribute to the dissociation of transport 
activity and NaPi-IIa abundance. 
     
 
 Plasma PTH rises in vivo and in vitro in response to a fall in ionized calcium or an 
increase in Pi concentrations. Whether the response to Pi is independent from calcium 
has remained unclear as Pi retains its ability to stimulate PTH secretion even in the 
absence of a measurable fall in ionized or total calcium25-27, 35, 41. Along the same line, in 
vitro incubation of human parathyroid glands with escalating concentrations of 
phosphate while keeping ionized calcium constant stimulated PTH secretion26, 41. On 
the other hand, inhibitors of Calcium-stimulated receptor (CaSR) mediated PTH 
secretion (calcimimetics) have been shown to suppress Pi induced PTH secretion in 
vivo suggesting a role of the CaSR even in the absence of changes of ionized calcium 
levels 27. Here, plasma total calcium decreased in parallel with the rise in PTH allowing 
no clear distinction between a calcium dependent or independent mechanism. However, 
infusion of 150 moles Pi caused a similar fall in plasma total calcium as 500 moles 
but the rise in PTH was blunted and detected only 10 minutes post administration, 
suggesting that Pi may stimulate PTH release synergistically or independently. The 
early response of PTH found in our animal model is consistent with experiments in 
humans and other rodent models 25, 34-35.  
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 PTH is critical for the early response to Pi, independent from the route of 
application. In PTX rats, massive and sustained hyperphosphatemia developed with a 
more pronounced fall in plasma total calcium than in intact rats. There was a small and 
transient increase in renal Pi excretion in the Pi infused PTX group that is most likely 
attributable to the combination of hyperphosphatemia and elevated glomerular filtration 
rate (as indicated by higher creatinine clearance). Phosphaturia ceased after 
normalization of creatinine clearance and the fall of plasma Pi below about 5 mM. The 
transient increase in creatinine clearance in the Pi infused animals is independent from 
PTH and may involve other Pi-sensitive mechanisms. The rise in plasma phosphate 
and/or the fall in plasma calcium may be (in)direct triggers affecting factors controlling 
glomerular filtration such as vascular tone of afferent and/or efferent arterioles where 
calcium channels play an important role 42. PTH is also required for the downregulation 
of renal Pi transporters after 4 hours as this response was also blunted in PTX rats. 
Thus, our results demonstrate that PTH is required for the early response to high Pi 
intake.   
 
  We detected only small or no changes in FGF23, 1,25-(OH)2-vitamin D3 , insulin, 
and dopamine. The increase in dopamine or FGF23 was found only at the latest time 
point and is probably not responsible for the massive phosphaturia at earlier time points. 
In Pi infused intact rats, the late rise in plasma dopamine (but not in urine) may enhance 
PTH induced phosphaturia. Dopamine acts via D1 receptors to downregulate NaPi-IIa in 
proximal tubules 9-11. The increase in FGF23 in PTX rats occurs between 50 and 240 
minutes after the Pi bolus (due to the small volumes of blood that could be collected 
only few FGF23 determinations were possible). This finding suggests first that in the 
absence of PTH, FGF23 levels adapt more acutely to the Pi overload, and second that 
systemic Pi can regulate FGF23 production and/or stability independently of PTH. 
Interestingly, FGF-23 production by osteocytes is not directly regulated by Pi 43 and 
instead requires previous production of PTH and activation of PKA and Wnt-pathways 
by PTHR1 25, 44-45  
 
 Intestinal Pi sensors and an intestine-derived phosphaturic factor had been 
postulated based on experiments with rats infused with Pi into duodenum. This 
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mechanism would allow for a rapid crosstalk between intestine and kidney and provide 
a feed-forward mechanism preventing a potentially detrimental hyperphosphatemia 24. 
The existence of such feed-forward mechanisms has been demonstrated for potassium 
and salt 46-49. However, Scanni et al had found in healthy humans that the rate of 
elimination and overall quantity of Pi excretion did not depend on the route of 
application (i.v. versus intraduodenal infusion)25. Consistently, our data do not provide 
any evidence for a role of the intestine in promoting phosphaturia. Moreover, in the 
absence of PTH, no phosphaturia could be elicited by intragastric Pi infusions. 
 
 The cumulative urinary elimination of the Pi bolus reached only about 50-60 % 
after 4 hours in intact animals whereas normophosphatemia was achieved much faster 
suggesting that a large amount of Pi had been either eliminated by other routes (i.e 
intestinal tract), or extravasated and accumulated in tissues, or complexed in blood into 
a pool that is not measurable by the Fiske-Subbarow method. Scanni et al showed that 
urinary excretion of Pi accounted for 100% of the intravenous Pi overload in humans, 
but full elimination required 120 hours 25; the authors rule out a contribution of the 
gastrointestinal tract in the elimination of Pi. We quantified the Pi content in femurs as 
well as liver and skeletal muscle. Pi content in bones is much higher than in the other 
two organs and the measured values were so high that a rough estimation of the total 
amount of Pi stored in the skeleton (assuming a 10% contribution to body weight and a 
comparable composition of all bones) suggests that even if all the non-excreted Pi 
would have been accumulated in bones this would only result in a small change of 
content (~0.5%), non-detectable with the Fiske-Subbarow method. Although similar 
estimations predicted that partial accumulation of Pi in liver and skeletal muscle could 
be detectable, we failed to observe any changes. Thus, other approaches should be 
used in order to identify the organ/s responsible for a transient accumulation of a large 
excess of Pi.  
 
 In summary, our data indicate that: a) normophosphatemia is rapidly re-
established after intravenous and intragastric Pi loading by mechanisms largely 
depending on the ability of the kidneys to excrete Pi, b) an efficient phosphaturic 
response requires increased levels of PTH and reduced expression of renal Pi 
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transporters, c) these compensatory responses are, to a major extent, similar whether 
or no Pi bypasses the gastrointestinal tract, and that d) reduced plasma Ca2+ together 
with elevated Pi may trigger the secretion of PTH in intravenously loaded animals. Our 
findings leave two major issues unresolved, namely the identity of the compartment 
responsible for the rapid “quenching” of a large fraction of the loaded Pi, and the nature 
of the signal that triggers the stimulation of PTH release.  
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CONCISE METHODS 
 
Animal Experimental Protocol 
 
Male Wistar rats (Charles River, Germany) weighing 250 - 350 g were adapted to a low 
Pi diet (0.1%) for 5 days. After an overnight fast in metabolic cages with free access to 
water, animals were anesthetized with 3% isoflurane/air, placed on a heated pad to 
maintain body temperature at 37 to 38°C. Rats inhaled constantly a low dose of 
anesthesia (1-2% isoflurane/air) until the end of the experiment. Catheters (BPE-T 50, 
Instech) were placed into the femoral vein, femoral artery, and urinary bladder (for 
infusion of solutions and collection of blood and urine, respectively). A Ringer’s solution 
(116 mM NaCl, 1.2 mM KCl, 1 mM CaCl2 and 2.7 mM NaHCO3) containing 5 % glucose 
was infused continuously at a rate of 3.0 ml /hr until the end of the experiment. To 
determine baseline values, blood and urine samples were collected over a period of 30 
minutes after the start of the Ringer infusion. In the infusion protocol, one milliliter of 
either Na2HPO4/NaH2PO4 (500, 150 or 50 mM, pH 7.4) or NaCl (500 or 150 mM, pH 
7.4) was infused immediately after the baseline sampling within 2-3 minutes. For 
gavage, one milliliter of either 500 mM NaH2PO4/Na2HPO4 (pH 5) or NaCl (500 or 150 
mM, pH 5) was administered directly into the stomach by using a gavage tube (FTP-15-
100, Instech). Blood and urine samples were collected at different time intervals of post 
infusion or gavage. At the end of sample collections (40 min or 4 hrs), the animals were 
sacrificed and blood, kidneys, intestine (duodenum, jejunum, and ileum), liver, muscle 
and femur were harvested. Blood samples (both from intermediate time points and at 
termination) were centrifuged immediately upon collection, and plasma was aliquoted. 
Plasma and organs were store at -80°C until further used.  
 
In addition, the identical experimental protocol to the one described above was 
performed in 350-450 g parathyrodectomized (PTX) male rats (Charles River) receiving 
1% calcium gluconate in drinking water.  
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All animal experiments were according to Swiss and international laws of animal 
protection and all protocols were approved by the appropriate local Veterinary Authority 
(Kantonales Veterinäramt Zürich). 
 
General analytical measurements 
 
The concentration of Pi in plasma and urine was determined according to the Fiske & 
Subbarow method (Randox). Plasma and urinary levels of calcium were measured 
using a Quantichrom calcium kit from Bioassay system. The concentration of creatinine 
in plasma was enzymatically measured using a peroxidase-antiperoxidase (PAP)-
creatinine kit (Biomed), whereas urinary creatinine was measured according to the Jaffe 
method. Fractional excretion of phosphate (FE(Pi)% was calculated using the formula: 
[urine phosphate x plasma creatinine] x100 / [plasma phosphate x urine creatinine]. The 
creatinine clearance was estimated from plasma and urinary creatinine concentrations 
and urine volume.  
 
The concentration of glucose in plasma was measured by using Accu-Chek (Roche). 
Enzyme-linked immunosorbent assays (ELISA) kits were used to measure the 
concentrations in plasma and/or of intact PTH (Immutopic), intact FGF 23 (Kainos), 
insulin (Crystal Chem Inc) and dopamine (LDN). Plasma 1,25-(OH)2 Vitamin D3 was 
determined with a radioimmunoassy (RIA) kit from IDS. Protein concentrations in renal 
BBM were determined with the Bio-Rad protein assay (Bio-Rad Laboratories). 
 
Isolation of renal brush border membrane vesicles (BBMV) and flux 
measurements of 32Pi and 3H-glucose  
 
Kidney cortex and medulla were dissected from frozen kidneys and upon 
homogenization in a buffer containing 300 mM Mannitol, 5 EGTA and 12 Tris-HCl, pH 
7.1, BBMV were isolated according to the Mg2+-precipitation method, as described in 
detail 50. Uptake of 32Pi and 3H-glucose were measured in three different solutions, all 
three containing 300 mM mannitol plus 20 mM HEPES-Tris, pH 7.4 and either 125 mM 
NaCl, 125 mM KCl or 125 mM NaCl plus 7.5 mM phosphonoformic acid (PFA). The 
uptake solutions contained either 0.125 M K2HPO4/KH2PO4, pH 7.4 as cold substrate 
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and 32Pi as a tracer, or 0.125 M D-glucose as cold substrate and 3H-D-glucose as 
tracer. To measure the incorporation of 32Pi /3H-glucose, 10 µl of freshly prepared 
BBMV were incubated for 1 minute or 2 hours with 40 µl of the different uptake 
solutions. The 1 min time point was chosen as 32Pi/3H-glucose uptake was in the linear 
phase of the maximal transport rate as determined earlier 50. After the indicated 
incubation time, uptakes were stopped by transferring 20 l of sample to 1 ml of ice cold 
stop solution (100 mM Mannitol, 5 mM Tris-HCl, 150 mM NaCl, 5 mM Pi, 5 mM 
glucose). The resulting suspension was then spotted onto a filter and vacuum- washed 
with 10 ml of ice cold stop solution. Filters were finally transferred into plastic vials and 
upon addition of 3 ml scintillation medium (Perkin Elmer) the retained radioactivity was 
measured on a β-counter (Packard, TRI-CARB 2900TR). All measurements were 
carried out in triplicate. The Na+ dependent uptakes were calculated by subtracting the 
uptake values obtained in the K+-medium from those measured in the Na+-medium 
(total uptake). Since PFA is a competitive inhibitor of SLC34 cotransporters (NaPi-IIa 
and NaPi-IIc), SLC34 mediated uptake was determined by subtracting the uptake 
values obtained in the presence of PFA from the Na+ dependent values.  The remaining 
BBMV that were not used in the uptake experiments were stored immediately at -80 0C 
for further experiments. 
 
Immunoblotting 
 
The protein expression levels of NaPi-IIa and NaPi-IIc in renal BBM were quantified by 
immunoblotting. To this end, 20 g of BBMs were solubilized in Laemmli's buffer and 
separated on 10% SDS-PAGE, and then transferred to polyvinylidene difluoride 
membranes (Millipore). After blocking non-specific binding with 5 % milk powder in Tris-
buffered saline containing 0.1% tween-20 for 40 min, the blots were incubated overnight 
at 4 0C with primary antibodies against NaPi-IIa (1: 4000)51, NaPi-IIc (1: 2500)52-53 and 
β-Actin (1:10000, Sigma Aldrich, Buchs, Switzerland). After washing and further 
blocking, blots were incubated with appropriate secondary antibodies for 2 hours at 
room temperature. Finally, membranes were exposed to chemiluminescent substrate for 
5 minutes and protein signals were detected on a LAS-4000 luminescent image 
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analyzer (Fujifilm). All the images were quantified with Advanced Image Data Analyzer 
(Raytest). The expression of both cotransporters was normalized to the abundance of β-
Actin.   
 
Determination of Phosphate in tissues 
 
Tissues (liver, skeletal muscle, and femur) collected from intact and 
parathyroidectomized rats 4 hours after infusion or gavage were dried in an oven at 
700C for 24 hours. Samples were weighed, transferred into a silica crucible and burned 
to ashes in an electric furnace at 7000C for 12 hours. 1N HCl was used to dissolve the 
Pi present in ashes and after centrifugation supernatants were collected for Pi 
determination by the above mentioned Fiske & Subbarow method.  
 
Statistical analysis 
Statistical significances were calculated by student's t-test or one-way ANOVA 
(Bonferroni), as indicated. P < 0.05 was considered significant. Results are presented 
as mean ± SEM. 
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FIGURE LEGENDS 
 
Figure 1. Effect of intravenous and intragastric administration of phosphate on 
body phosphate distribution and renal excretion in intact rats  
Rats were loaded with 500 moles Pi or saline intravenously or orally. (A) plasma Pi, 
(B) urinary Pi/creatinine, (C) creatinine clearance, and (D) cumulative Pi excretion. (E) 
concentration of Pi in femur, (F) concentration of Pi in skeletal muscle, (G) 
concentration of Pi in liver. Four profiles are shown: saline intravenous infusion (black), 
Pi intravenous infusion (red), saline intragastric gavage (green) and Pi intragastric 
gavage (blue). Data are presented as the mean ± SEM. *P< 0.05  or **P <0.01 or *** P< 
0.001 vs. time 0, Anova test, n = 5-9/group and time point.  
 
Figure 2. Effect of intravenous and intragastric administration of phosphate on 
Ca2+ plasma levels and urinary excretion in intact rats  
Rats were loaded with 500 moles Pi or saline intravenously or orally. (A) plasma Ca2+, 
(B) urinary Ca2+/ creatinine. Four profiles are shown: saline intravenous infusion (black), 
Pi intravenous infusion (red), saline intragastric gavage (green) and Pi intragastric 
gavage (blue). Data are presented as the mean ± SEM. *P< 0.05 vs. time 0, Anova test, 
n = 5-9/group and time point.  
 
Figure 3. Effect of intravenous and intragastric administration of phosphate on 
hormonal levels in intact rats  
Rats were loaded with 500 moles Pi or saline intravenously or orally. (A) plasma intact 
Parathyroid hormone (PTH), (B) plasma intact FGF23, (C) plasma 1,25-(OH)2 vitamin 
D3, (D) plasma insulin, (E) plasma dopamine, and (F) urine dopamine. Four profiles are 
shown: saline intravenous infusion (black), Pi intravenous infusion (red), saline 
intragastric gavage (green) and Pi intragastric gavage (blue). Data are presented as the 
mean ± SEM. *P< 0.05 vs. time 0, Anova test, n = 5-9/group and time point.  
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Figure 4. Effect of intravenous and intragastric administration of phosphate on 
phosphate and glucose transport activities in renal brush border membrane 
vesicles from intact rats  
Rats were loaded with 500 moles Pi or saline intravenously or orally. Kidneys were 
extracted 40 minutes or 4 hours after infusion or gavagepost administration and Na+-
dependent and -independent Pi and glucose transport activities measured. Pi transport 
was assayed in the presence or absence of the SLC34 transport inhibitor 
phosphonoformic acid (PFA).  (A) 32P-uptakes 40 minutes after intravenous infusion of 
saline (grey bars) and Pi (black bars), (B) 32P-uptakes 40 minutes after intragastric 
administration of saline (grey bars) and Pi (black bars), (C) 32P-uptakes 4 hours after 
intravenous infusion of saline (grey bars) and Pi (black bars), (D) 32P-uptakes 4 hours 
after intragastric administration of saline (grey bars) and Pi (black bars),  (E) 3H-D-
glucose uptakes 40 minutes after intravenous and intragastric administration of saline 
(grey bars) and Pi (black bars), (F) 3H-D-glucose uptakes 4 hours after intravenous and 
intragastric administration of saline (grey bars) and Pi (black bars). Data are presented 
as the mean ± SEM. *P< 0.05 versus saline group, Unpaired Student's t-test, n = 5-
9/group and time point.  
. 
Figure 5. Effect of intravenous and intragastric administration of phosphate on 
the expression of renal Na/Pi-cotransporters in intact rats  
Rats were loaded with 500 moles Pi or saline intravenously or orally. Kidneys were 
extracted 40 minutes or 4 hours post administration and the abundance of NaPi-IIa and 
NaPi-IIc in BBM was determined by Western blot. Expression of cotransporters (A) 40 
minutes after intravenous infusion of saline (grey bars) and Pi (black bars), (B) 40 
minutes after intragastric administration of saline (grey bars) and Pi (black bars), (C) 4 
hours after intravenous infusion of saline (grey bars) and Pi (black bars), (B) 4 hours 
after intragastric administration of saline (grey bars) and Pi (black bars). *P< 0.05 
versus saline group, Unpaired Student's t-test, n = 5-9/group and time point. 
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Figure 6. Effect of intravenous and intragastric administration of phosphate on 
body phosphate distribution and renal excretion in parathyroidectomized rats  
Parathyroidectomized rats were loaded with 500 moles Pi or saline intravenously or 
orally. (A) plasma Pi, (B) urinary Pi/creatinine, (C) creatinine clearance, and (D) 
accumulative Pi excretion. (E) concentration of Pi in femur, (F) concentration of Pi in 
skeletal muscle, (G) concentration of Pi in liver. Four profiles are shown: saline 
intravenous infusion (black), Pi intravenous infusion (red), saline intragastric gavage 
(green) and Pi intragastric gavage (blue). Data are presented as the mean ± SEM. *P< 
0.05 or **P <0.01 vs. time 0, Anova test, n = 4-6/group and time point.  
 
Figure 7. Effect of intravenous and intragastric administration of phosphate on 
Ca2+ plasma levels and urinary excretion in parathyroidectomized rats  
Parathyroidectomized rats were loaded with 500 moles Pi or saline intravenously or 
orally. (A) plasma Ca2+, (B) urinary Ca2+/creatinine. Four profiles are shown: saline 
intravenous infusion (black), Pi intravenous infusion (red), saline intragastric gavage 
(green) and Pi intragastric gavage (blue). Data are presented as the mean ± SEM. *P< 
0.05 vs. time 0, Anova test, n = 4-6/group and time point.  
 
Figure 8. Effect of intravenous and intragastric administration of phosphate on 
hormonal levels in parathyroidectomized rats  
Parathyroidectomized rats were loaded with 500 moles Pi or saline intravenously or 
orally. (A) plasma intact PTH, (B) plasma intact FGF23, (C) plasma 1,25-(OH)2 vitamin 
D3, (D) plasma insulin, (E) plasma dopamine, and (F) urine dopamine. Four profiles are 
shown: saline intravenous infusion (black), Pi intravenous infusion (red), saline 
intragastric gavage (green) and Pi intragastric gavage (blue). Data are presented as the 
mean ± SEM. *P< 0.05 vs. time 0, Anova test, n = 4-6/group and time point.  
 
Figure 9. Effect of intravenous and intragastric administration of phosphate on 
phosphate and glucose transport activities in renal brush border membrane 
vesicles from parathyroidectomized rats  
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Parathyroidectomized rats were loaded with 500 moles Pi or saline intravenously or 
orally. Kidneys were extracted 4 hours after infusion or gavagepost administration and 
Na+-dependent and -independent Pi and glucose transport activities in isolated brush 
border membrane vesicles measured. Pi transport was assayed in the presence or 
absence of the SLC34 transport inhibitor phosphonoformic acid (PFA). (A) 32P-uptakes 
4 hours after intravenous infusion of saline (grey bars) and Pi (black bars), (B) 32P-
uptakes 4 hours after intragastric administration of saline (grey bars) and Pi (black 
bars), (C) 3H-D-glucose uptakes 4 hours after intravenous and intragastric 
administration of saline (grey bars) and Pi (black bars). Data are presented as the mean 
± SEM. *P< 0.05 versus saline group, unpaired Student's t-test, n = 4-6/group and time 
point.  
 
Figure 10. Effect of intravenous and intragastric administration of phosphate on 
the expression of renal Na/Pi-cotransporters in parathyroidectomized rats 
Parathyroidectomized rats were loaded with 500 moles Pi or saline intravenously or 
orally. Kidneys were extracted 4 hours post administration and the abundance of NaPi-
IIa and NaPi-IIc in BBM was determined by Western blot. Expression of cotransporters 
(A) 4 hours after intravenous infusion of saline (grey bars) and Pi (black bars), (B) 4 
hours after intragastric administration of saline (grey bars) and Pi (black bars). *P< 0.05 
versus saline group, unpaired Student's t-test, n = 4-6/group and time point.  
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SUPPLEMENTARY FIGURES 
 
Supplementary Figure 1. Effect of different doses of intravenous Phosphate 
loading on several parameters in intact rats 
Rats were loaded with 50, 150, or 500 moles Pi intravenously (A) plasma Pi, (B) 
urinary Pi/creatinine, (C) plasma Ca2+, D) urinary Ca2+/creatinine, (E) intact PTH. 
Three profiles are shown: 50 moles Pi (black), 150 moles Pi (blue), 500 moles Pi 
(red). Data are presented as the mean ± SEM. *P< 0.05 or **P <0.01 or *** P< 0.001 
vs. time 0. Anova test, n = 5-9/group and time point. 
 
Supplementary Figure 2. Effect of different concentrations of intravenous and 
intragastric administration of NaCl on several parameters in intact rats  
Rats were loaded with 150 or 500 moles NaCl intravenously or orally. (A) plasma Pi, 
(B) urinary Pi, (C) plasma Ca2+ , D) urinary Ca2+. Four profiles are shown: 
intravenous 150 moles NaCl (black), intravenous 500 moles NaCl  (red), 
intragastric 150 moles NaCl (green), intrasgrastic  500 moles NaCl (blue). Data are 
presented as the mean ± SEM. *P< 0.05 vs. time 0. Anova test, n = 5-9/group and 
time point. 
 
Supplementary Figure 3. Effect of intravenous and intragastric administration 
of Pi on fractional Pi excretion in intact and parathyroidectomized rats  
Rats were loaded with 500 moles Pi or saline intragastrically or intravenously. (A) 
FE (%) for Pi in intact rats, (B) FE (%) for Pi in parathyroidectomized rats. Four 
profiles are shown: saline intravenous infusion (black), Pi intravenous infusion (red), 
saline intragastric gavage (green) and Pi intragastric gavage (blue). Data are 
presented as the mean ± SEM. *P< 0.05 vs. time 0, Anova test, n = 4-9/group and 
time point.  
 
Supplementary Figure 4. Effect of intravenous and intragastric administration 
of phosphate on body phosphate distribution in intact rats  
Rats were loaded with 500 moles Pi or saline intravenously or orally. (A) 
Concentration of Pi in femur, (B) concentration of Pi in skeletal muscle, (C) 
concentration of Pi in liver. Data are presented as the mean ± SEM. Anova test, n = 
5-9/group and time point. 
PTH controls acute phosphate clearance 
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Supplementary Figure 5. Effect of intravenous and intragastric administration 
of phosphate on body phosphate distribution in parathyroidectomized rats  
Parathyroidectomized rats were loaded with 500 moles Pi or saline intravenously or 
orally. (A) Concentration of Pi in femur, (B) concentration of Pi in skeletal muscle, (C) 
concentration of Pi in liver. Data are presented as the mean ± SEM, Anova test, n = 
4-6/group and time point.  
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